Brightlands Venture Partners

Mane Biotech is a venture-funded startup making hair loss prevention and hair regrowth possible by using regenerative medicine. The human body displays remarkable abilities to heal and regenerate due to the function of adult stem cells. At Mane Biotech, we are unlocking the body's regeneration potential to grow hair. We are developing a smart, wearable device to regrow hair and stop hair loss in people with Androgenetic Alopecia.

Neuroplast B.V., founded in 2013 and based in Geleen, the Netherlands, operates a stem cell manufacturing laboratory specializing in the development of low immunogenic stem cells. These innovative stem cells aim to provide therapeutic solutions for patients afflicted with neurodegenerative diseases. The company is positioned within the field of neuro-regenerative personalized medicine, which is recognized as a promising area of therapy requiring consistent standards and regulations to ensure effective treatment outcomes.

Qorium is a biotech company that provides premium, cell-cultured collagen-based leather.

Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

Neuroplast B.V., founded in 2013 and based in Geleen, the Netherlands, operates a stem cell manufacturing laboratory specializing in the development of low immunogenic stem cells. These innovative stem cells aim to provide therapeutic solutions for patients afflicted with neurodegenerative diseases. The company is positioned within the field of neuro-regenerative personalized medicine, which is recognized as a promising area of therapy requiring consistent standards and regulations to ensure effective treatment outcomes.

VACIS is the leading tissue engineering company for body-own blood vessels.VACIS develops in situ tissue engineered blood vessels providing novel therapeutic options for vascular surgery. Prosthetic vascular graft failure is a frequent complication in vascular surgery with substantial morbidity and health care costs. VACIS provides patients autologous graft vessels, with sustained patency and fewer complications requiring less corrective interventions.

Grassa B.V., founded in 2014 and headquartered in Venlo, Netherlands, specializes in upgrading grass and crops through a process known as bio refining. The company focuses on maximizing the value of plant materials by extracting proteins, fibers, and minerals from grass and vegetable waste to create high-quality animal feed and protein supplements. Utilizing a mobile refining machine, Grassa processes fresh grass from pastures, agricultural by-products, invasive aquatic plants from rivers, and natural grass from protected areas. The bio refining process results in four key products: fibers, protein, phosphate, and sap.

Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel. Osteoarthritis is the 4th leading cause of mobility associated disability and affects more than 100 million patients in the Western world, who are all in need for an effective treatment. It is the aim of Hy2Care to change the future for patients suffering from osteoarthritis.